Fecal Microbiota Transplantation is a Promising Switch Therapy for Patients with Prior Failure of Infliximab in Crohn's Disease

• Главные авторы: Qianqian Li (Автор), Xiao Ding (Автор), Yujie Liu (Автор), Cicilia Marcella (Автор), Min Dai (Автор), Ting Zhang (Автор), Jianling Bai (Автор), Liyuan Xiang (Автор), Quan Wen (Автор), Bota Cui (Автор), Faming Zhang (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2021-05-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: How to handle patients with anti-tumor necrosis factor (anti-TNF) failure was a common challenge to clinicians in Crohn's disease (CD). The present study is dedicated to clarifying whether fecal microbiota transplantation (FMT) could be a switch therapy for patients with prior failu...